Search research articles
Contact Us
Filters
Showing results (31-40 of 802) with videos related to
Page
of 81
Sort By:
Treatments in Respiratory Medicine
|
March 4, 2006
Application of Number Needed to Treat (NNT) as a Measure of Treatment Effect in Respiratory Medicine
Mario Cazzola
Haematologica
|
May 3, 2008
Molecular basis of thrombocytosis
Mario Cazzola
Haematologica
|
July 15, 2003
Genetic disorders of iron overload and the novel "ferroportin disease"
Mario Cazzola
Haematologica
|
July 2, 2008
Myelodysplastic syndrome with isolated 5q deletion (5q- syndrome). A clonal stem cell disorder characterized by defective ribosome biogenesis
Mario Cazzola
Haematologica
|
March 9, 2004
Towards a rational treatment of essential thrombocythemia, despite limited evidence and old prejudices
Mario Cazzola
Therapeutic Advances in Respiratory Disease
|
June 26, 2009
Retraction: high, but not low, molecular weight preparations of hyaluronic acid protect asthmatics against challenge-induced bronchoconstriction
Mario Cazzola
The New England Journal of Medicine
|
December 28, 2020
Myelodysplastic Syndromes. Reply
Mario Cazzola
Best Practice & Research. Clinical Haematology
|
March 2, 2005
Role of ferritin and ferroportin genes in unexplained hyperferritinaemia
Mario Cazzola
Blood
|
April 13, 2016
Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues
Mario Cazzola
Hematology. American Society of Hematology. Education Program
|
December 17, 2008
Iron in hematology: an historical perspective
Mario Cazzola
Page
of 81
Search research articles
Search
Showing results (31-40 of 802) with videos related to
Sort By:
Page
of 81
Treatments in Respiratory Medicine
|
March 4, 2006
Application of Number Needed to Treat (NNT) as a Measure of Treatment Effect in Respiratory Medicine
Mario Cazzola
Haematologica
|
May 3, 2008
Molecular basis of thrombocytosis
Mario Cazzola
Haematologica
|
July 15, 2003
Genetic disorders of iron overload and the novel "ferroportin disease"
Mario Cazzola
Haematologica
|
July 2, 2008
Myelodysplastic syndrome with isolated 5q deletion (5q- syndrome). A clonal stem cell disorder characterized by defective ribosome biogenesis
Mario Cazzola
Haematologica
|
March 9, 2004
Towards a rational treatment of essential thrombocythemia, despite limited evidence and old prejudices
Mario Cazzola
Therapeutic Advances in Respiratory Disease
|
June 26, 2009
Retraction: high, but not low, molecular weight preparations of hyaluronic acid protect asthmatics against challenge-induced bronchoconstriction
Mario Cazzola
The New England Journal of Medicine
|
December 28, 2020
Myelodysplastic Syndromes. Reply
Mario Cazzola
Best Practice & Research. Clinical Haematology
|
March 2, 2005
Role of ferritin and ferroportin genes in unexplained hyperferritinaemia
Mario Cazzola
Blood
|
April 13, 2016
Introduction to a review series: the 2016 revision of the WHO classification of tumors of hematopoietic and lymphoid tissues
Mario Cazzola
Hematology. American Society of Hematology. Education Program
|
December 17, 2008
Iron in hematology: an historical perspective
Mario Cazzola
Page
of 81